Retesting the childhood-onset GH-deficient patient.

GH deficiency (GHD) in adults has to be shown by a single provocative test, provided that it is validated. Insulin tolerance test (ITT) has been indicated as the test of choice; now also glucagon test is validated and represents an alternative. The GHRH plus arginine (ARG) test and testing with GHRH plus a GH secretagogue are equally reliable diagnostic tools, and are now considered as 'golden' standards as ITT. Childhood-onset (CO) GHD needs retesting in late adolescence or young adulthood; this is a major clinical challenge and raises questions about the most appropriate method and cut-off value. Appropriate re-evaluation of GH status is represented by simple measurement of IGF1 concentration off rhGH treatment. Clearly, low IGF1 levels are evidence of persistent severe GHD in subjects with genetic GHD or panhypopituitarism. However, normal IGF1 levels never rule out severe GHD and CO-GHD with normal IGF1 levels must undergo a provocative test. The appropriate GH cut-off limit is specific for each provocative test. As shown by the ROC curve analysis, in late adolescents and young adults, the lowest normal GH peak response to ITT is 6.1 microg/l while that to GHRH+ARG test is 19.0 microg/l. These cut-off limits, however, are just indicative as being variable as a function of the assay used. No other test is validated for retesting. As GHRH+ARG test mostly explores the GH-releasable pool, normal GH response would be verified by a second ITT in order to rule out subtle hypothalamic defect.

[1]  G. Beccuti,et al.  Diagnosis of adult GH deficiency , 2008, Pituitary.

[2]  M. Maghnie,et al.  Cut-off limits of the GH response to GHRH plus arginine test and IGF-I levels for the diagnosis of GH deficiency in late adolescents and young adults. , 2007, European journal of endocrinology.

[3]  E. Ghigo,et al.  Traumatic brain injury and hypopituitarism in children and adolescents: is the problem under-estimated? , 2007, Pediatric endocrinology reviews : PER.

[4]  K. Ho,et al.  Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II : a statement of the GH Research Society in association with the European Society for Pediatric , 2007 .

[5]  F. Casanueva,et al.  Effect of obesity and morbid obesity on the growth hormone (GH) secretion elicited by the combined GHRH + GHRP‐6 test , 2006, Clinical endocrinology.

[6]  M. Vance,et al.  CLINICAL PRACTICE GUIDELINE Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline , 2006 .

[7]  S. Grottoli,et al.  The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. , 2005, European journal of endocrinology.

[8]  M. Maghnie,et al.  Diagnosis of GH deficiency in the transition period: accuracy of insulin tolerance test and insulin-like growth factor-I measurement. , 2005, European journal of endocrinology.

[9]  C. Garel,et al.  Do all patients with childhood-onset growth hormone deficiency (GHD) and ectopic neurohypophysis have persistent GHD in adulthood? , 2005, The Journal of clinical endocrinology and metabolism.

[10]  P. Clayton,et al.  Consensus statement on the management of the GH-treated adolescent in the transition to adult care. , 2005, European journal of endocrinology.

[11]  M. Vaisman,et al.  Glucagon stimulation test for the diagnosis of GH deficiency in adults , 2003, Journal of endocrinological investigation.

[12]  M. Miras,et al.  Evaluation of diagnostic accuracy of insulin-like growth factor (IGF)-I and IGF-binding protein-3 in growth hormone-deficient children and adults using ROC plot analysis. , 2003, The Journal of clinical endocrinology and metabolism.

[13]  S. Grottoli,et al.  Diagnostic reliability of a single IGF‐I measurement in 237 adults with total anterior hypopituitarism and severe GH deficiency , 2003, Clinical endocrinology.

[14]  E. Ghigo,et al.  The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. , 2003, The Journal of clinical endocrinology and metabolism.

[15]  D. Cook,et al.  Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. , 2002, The Journal of clinical endocrinology and metabolism.

[16]  C. Quigley,et al.  Confirmation of severe GH deficiency after final height in patients diagnosed as GH deficient during childhood , 2002, Clinical endocrinology.

[17]  J. Mesa,et al.  Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults , 2002, Clinical endocrinology.

[18]  Brenda J. Crowe,et al.  Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? , 2002, The Journal of clinical endocrinology and metabolism.

[19]  J. Svensson,et al.  Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study. , 2001, The Journal of clinical endocrinology and metabolism.

[20]  P. Marzullo,et al.  Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults. , 2001, The Journal of clinical endocrinology and metabolism.

[21]  Growth Hormone Research Society,,et al.  Consensus Guidelines for the Diagnosis and Treatment of Growth Hormone (GH) Deficiency in Childhood and Adolescence: Summary Statement of the GH Research Society , 2001 .

[22]  M. M. Ilondo,et al.  Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH research society , 2000 .

[23]  E. Arvat,et al.  Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test. , 2000, The Journal of clinical endocrinology and metabolism.

[24]  F. Casanueva,et al.  GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults , 2000, The Lancet.

[25]  S. Grottoli,et al.  The GH/IGF-I axis in obesity: influence of neuroendocrine and metabolic factors , 2000, International Journal of Obesity.

[26]  A. Lucas,et al.  Diagnostic efficiency of serum IGF-I, IGF-binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and urinary GH measurements in the diagnosis of adult GH deficiency: importance of an appropriate reference population. , 2000, European journal of endocrinology.

[27]  M. Thorén,et al.  Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects. , 1999, The Journal of clinical endocrinology and metabolism.

[28]  M. Maghnie,et al.  Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. , 1999, The Journal of clinical endocrinology and metabolism.

[29]  E. Ghigo,et al.  Usefulness of IGF-I assay for the diagnosis of GH deficiency in adults , 1998, Journal of endocrinological investigation.

[30]  E. Arvat,et al.  Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. , 1998, The Journal of clinical endocrinology and metabolism.

[31]  E. Ghigo,et al.  Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. , 1998, The Journal of clinical endocrinology and metabolism.

[32]  S. Shalet,et al.  Diagnosis of severe growth hormone (GH) deficiency in young adults who received GH replacement therapy during childhood , 1997, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[33]  J. Coste,et al.  Growth hormone testing for the diagnosis of growth hormone deficiency in childhood: a population register-based study. , 1997, The Journal of clinical endocrinology and metabolism.

[34]  H. C. Hoeck,et al.  Reproducibility of Growth Hormone and Cortisol Responses to the Insulin Tolerance Test and the Short ACTH Test in Normal Adults , 1997, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[35]  C. Pienkowski,et al.  Growth hormone (GH) retesting and auxological data in 131 GH-deficient patients after completion of treatment. , 1997, The Journal of clinical endocrinology and metabolism.

[36]  S. Lamberts,et al.  Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group. , 1997, The Journal of clinical endocrinology and metabolism.

[37]  F. Dammacco,et al.  Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. , 1996, The Journal of clinical endocrinology and metabolism.

[38]  H. C. Hoeck,et al.  Test of growth hormone secretion in adults: poor reproducibility of the insulin tolerance test. , 1995, European journal of endocrinology.

[39]  I. Robinson,et al.  Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action. , 1995, The Journal of endocrinology.

[40]  E. Ghigo,et al.  Growth hormone response to oral clonidine test in normal and short children , 1993, Journal of endocrinological investigation.

[41]  J. Kaufman,et al.  Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. , 1992, The Journal of clinical endocrinology and metabolism.

[42]  S. Zucchini,et al.  Variability of growth hormone response to pharmacological and sleep tests performed twice in short children. , 1990, The Journal of clinical endocrinology and metabolism.

[43]  N. Skakkebaek,et al.  BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS , 1989, The Lancet.